Latest Conference Articles

Patients diagnosed with Parkinson's disease face a wide range of physical ailments with their condition. One of the lesser addressed areas is the psychological aspects they face as well. Therapeutic alternatives are being developed to help treat psychosis in this particular patient group.

Research has shown how important sleep can be for a person's health. For patients with insomnia every little bit helps and medications have been developed for this specific condition with some having more serious side effects than others.

When doctors are considering medications to prescribe to patients there are several factors they need to consider, not the least of which is cost.

Rivaroxaban, also known as Xarelto has been on the market for many years but was recently approved for use in patients with DVT and pulmonary embolism.

With primary care physicians treating such a broad spectrum of conditions they also have a number of medications they can prescribe to help their patients. While some of these are more beneficial than others it is important to consider which might be more effective for patients.

Hyperkalemia can be a significant diagnosis for patients and finding the right treatment can have a great impact on their quality of life. New medications could help in their daily care.

Hypertension is a common diagnosis in patients and can often require patients to visit their doctors on a regular basis. A new approach to treatment could mean fewer trips for patients while providing a high level of care at the same time.

Medications in general can take a long time to develop. Depending on the condition they treat that process can be even longer as more questions have to be answered before they can be introduced to the field. This is particularly true of multiple sclerosis treatments.

As a treatment for multiple sclerosis teriflunomide has shown benefits over a long development period and has proven effective in the treatment of patients with the relapsing-remitting form of the condition.

For as many drugs and therapies as there are for multiple sclerosis some are more aggressive than others. Alemtuzumab's approach is more on the aggressive end of the spectrum.

Epilepsy is a well known condition both in the medical community and in the general public. Despite that there is still a considerable amount of misinformation that can affect a person's willingness to seek treatment and know what to expect during the process.

Using the new guidelines set forth by the American Academy of Neurology should help doctors and patients understand how best to proceed as more is learned about the affects of first seizures and factors that could contribute to future occurrences.

When a patient suffers their first seizure their initial reaction may be to seek immediate medical and pharmaceutical care to ensure there are no subsequent events. Doctors themselves may look for quick fixes rather than longer lasting remedies.

Patients who suffer their first seizure are expected to have several questions. In some instances, one question may be why their doctor is waiting until a second seizure to begin treatment. A new guideline from the American Academy of Neurology looked to answer that question for doctors and patients alike.

As more is learned about the diagnosis and treatment of CIDP the medical community is also learning how best to work with patients with the condition.

Sometimes symptoms of CIDP can closely resemble those of other conditions. In light of this it is important for doctors to take a closer look to ensure a proper diagnosis is made.

Doctors treating patients with pediatric multiple sclerosis often turn to the same treatments as adult patients. While there are some unique characteristics and more work is being done in the field, these seem to give the best hope of maintaining a high quality of life for the young patients.

Getting a proper diagnosis for pediatric multiple sclerosis is not an easy task and requires a partnership between doctors, patients and their families.

Despite the wealth of choices physicians have in finding drugs to treat hepatitis C infection, two challenges remain in eradicating the disease-price and lack of global screening for the virus.

A lot of attention in the field of multiple sclerosis is being dedicated to neuroprotection and remyelination. Whether these can someday lead to more effective treatments remains to be seen but there is optimism among doctors and researchers alike.

Lise Lotte Gluud, MD, DmSc, shared some of the best practices she and her colleagues learned through their own research at The International Liver Congress 2015 Vienna, Austria.

A lot of work is being put into developing ways to diagnose and treat patients with Alzheimer's Disease now. Even as work for the present is being done researchers are are also looking toward the future and what could be coming down the road.

Video Interview: Vinood Patel, PhD, PGCHE, fHEA, FRSC, University of Westminster, London, UK, discussed his hope for hepatologists to better understand the mechanisms that lead from fatty liver to steatohepatitis and subsequently from steatohepatitis to cirrhosis at The International Liver Congress 2015.

The understanding of Alzheimer's Disease has shown a lot of progression in recent years. One area that has not found a definitive new direction is diagnosis, which typically can only be done through autopsy. New technology could allow doctors to see the disease before it affects a person's life.

As with all forms of medicine there are challenges associated with treating patients with hyperkinetic movement disorders. How doctors tackle those challenges can range from work in specialty clinics to consulting with patients through telemedicine.

The opioid epidemic began nearly 30 years ago and since that time small steps have been taken to reverse its effects. The question remains whether too much damage has already been done to fix the problems in a timely manner.

For many years the dangers of opioid addiction have been well known. Taking the steps needed to reverse its impact has been slower in taking hold across the country.

There are some movement disorders that are commonly seen by healthcare professionals and some that fall more into the rare category. Properly diagnosing and treating them can make a big difference in a patient's quality of life.

As one of the first signs of multiple sclerosis acute optic neuritis can be a worrying symptom for patients. Finding the proper treatment can be important in the early stages of diagnosis.

For many patients medication and surgery can be enough to help them maintain their health and control epileptic seizures. Work is also being done in the field to find alternative therapies including medical marijuana and seizure predicting devices.